Kane Biotech (KNBIF) 0.0353 $KNBIF Kane Biotech

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kane Biotech (KNBIF) 0.0353 $KNBIF

Kane Biotech Announces Joint Development Agreement and Channel Expansion
Marketwired - Wed May 13, 7:02AM CDT
Kane Biotech Inc. (TSX VENTURE: KNE), is a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms. The Company's current focus is on the animal oral care market.
KNE.VN: 0.045 (-0.005)

Kane Biotech Announces Change in Executive Leadership
Marketwired - Mon May 11, 6:31AM CDT
Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms today announced Gord Froehlich will retire as Chief Executive Officer. The Board has appointed Mark Ahrens-Townsend as President and CEO to replace Froehlich, effective May 11, 2015.
KNE.VN: 0.045 (-0.005)

Kane Biotech Summarizes Compelling Oral Care Study Results
Marketwired - Thu Mar 26, 7:01AM CDT
Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company developing and commercializing products that prevent and remove microbial biofilms, is pleased to provide a summary of the efficacy and safety study results on its companion animal oral care water additive. The studies were conducted by independent third party research organizations.
KNE.VN: 0.045 (-0.005)

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest
Marketwired - Tue Mar 24, 7:03AM CDT
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Corporation" announced that on March 23, 2015, it issued 248,605 common shares of the Corporation ("Common Shares" in payment of $12,430.27 in interest owing on the Corporation's $500,000 2 year 10% convertible redeemable unsecured note (the "Note" as at March 18, 2015. Pursuant to the terms of the Note, the Corporation has the option to issue Common Shares in lieu of cash in payment of interest on the Note at a deemed price per share equal to the market price of the Common Shares on the applicable interest payment date, subject to a minimum price of $.05 per share and the approval of the TSX Venture Exchange (the "Exchange". The approval of the Exchange for the issuance of the Common Shares was obtained by the Corporation on March 23, 2015. The Common Shares issued by the Corporation are restricted from transfer for a period of four months from the date of issuance in accordance with applicable securities laws and TSX Venture Exchange policies.
KNE.VN: 0.045 (-0.005)

Kane Biotech Introduces bluestem(TM)
Marketwired - Thu Feb 12, 8:26AM CST
Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company developing and commercializing products that prevent and remove microbial biofilms announces that it will be introducing the company's bluestem pet oral care brand in the over the counter (OTC) retail market.
KNE.VN: 0.045 (-0.005)

Kane Biotech Announces Grant of Options
Marketwire Canada - Mon Jan 12, 9:01AM CST
Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, announces that the Company has granted an aggregate of 3,865,000 stock options at an exercise price of $.07 per common share to directors, management, employees and consultants of the Company. The options pursuant to the Corporation's stock option plan and are subject to TSX Venture Exchange acceptance. In accordance with securities regulatory requirements, any shares issued pursuant to the exercise of such options will be subject to resale restriction for a period of four months from the date of the grant.
KNE.VN: 0.045 (-0.005)

Kane Biotech Announces Second Closing of Private Placement Offering
Marketwired - Wed Dec 17, 10:28AM CST
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Company" or "Kane Biotech", a biotechnology company engaged in the development of products that prevent and remove microbial biofilms, has completed the second closing of its current private placement offering (the "Offering" with additional aggregate gross proceeds to the Company of $50,000 from the sale of 1,000,000 units ("Units" at a price of $0.05 per Unit. Each Unit is comprised of one common share of the Company (a "Share" and one Share purchase warrant (a "Warrant". Each Warrant will expire 18 months from the date the Warrant is issued (the "Expiry Date" and will entitle the holder to purchase one Share at a price of $0.06 up to the Expiry Date. The total amount raised by Kane at the first and second closings of the Offering is $1,225,000 from the sale of 24,500,000 Units.
KNE.VN: 0.045 (-0.005)

Kane Biotech Announces Closing of Private Placement Offering
Marketwired - Tue Dec 09, 7:04AM CST
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Company" or "Kane Biotech", a biotechnology company engaged in the development of products that prevent and remove microbial biofilms, has closed its previously announced private placement offering (the "Offering" with aggregate gross proceeds to the Company of $1,175,000 from the sale of 23,500,000 units ("Units" at a price of $0.05 per Unit. Each Unit is comprised of one common share of the Company (a "Share" and one Share purchase warrant (a "Warrant". Each Warrant will expire 18 months from the date the Warrant is issued (the "Expiry Date" and will entitle the holder to purchase one Share at a price of $0.06 up to the Expiry Date.
KNE.VN: 0.045 (-0.005)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PolyBio Convergence Summit Tackles Aging, Chronic Illness

Updated Category News Views 146

Kicking Off The Convergence: Pathogens in Focus Here's a gathering that's set to challenge how we think about lingering illnesses and aging. PolyBio Research Foundation is bringing a powerhouse of brains to the table with their inaugural Convergence Summit. It's more than just science talk; it's a chance to push boundaries in understanding how pathogens stick around and...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 69

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 142

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 155

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 87

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 71

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Thread AI Joins Microsoft Pegasus: Big AI Leap

Updated Category News Views 26

Thread AI Leaps Ahead with Microsoft Partnership There's excitement in the air as Thread AI joins forces with Microsoft by entering the exclusive Pegasus Program. In the ever-evolving world of AI, making a splash this big doesn't happen every day. People in the tech alley are buzzing, and it looks like Thread AI is ready to rumble on a larger stage—much like a scrappy...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 85

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 67

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 135

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading

Top 5 Most Recently Viewed Articles

Conagra Brands: Navigating Challenges with Strong Dividends and Growth

Updated Category News Views 164

Conagra's Market Position and Opportunities Conagra Brands Inc (NYSE: CAG) shares are currently experiencing a significant dip, providing a favorable opportunity for long-term investors to consider entry into the market. Despite the ongoing challenges that are affecting the consumer staples sector, Conagra has ended its recent business contraction. The company's...

Continue Reading
Unlocking the Potential of AeroVironment Stock Investments

Updated Category News Views 215

The Growth Journey of AeroVironment (NASDAQ: AVAV) AeroVironment continues to impress investors with its steady performance over recent years. This aerospace company specializes in drone technology and has showcased remarkable growth potential in a competitive industry. Despite the challenges posed by changing market conditions, AeroVironment has outperformed the market...

Continue Reading
Focal One® Robotic HIFU Shows Promise in Prostate Cancer Care

Updated Category News Views 131

Groundbreaking Results from the HIFI Study The HIFI Study stands as a significant milestone in the treatment of localized prostate cancer, presenting remarkable findings and setting the stage for a shift in medical practices. This extensive research, with a participant group of 3,328, compares HIFU treatment using Focal One® against traditional surgery methods,...

Continue Reading
VENU's Ambitious Growth Strategy Secures $34.5 Million Funding

Updated Category News Views 307

VENU Secures Funding to Propel Its Growth Strategy In recent news, VENU (NYSE American: VENU), a company leading the charge in premium hospitality and live entertainment, has successfully closed a public offering. This offering involved 2,875,000 shares of common stock, sold at a public price of $12.00 each, bringing in $34.5 million in gross proceeds. This substantial...

Continue Reading
Exploring Market Trends in the Food Colors Industry

Updated Category News Views 250

The food colors market saw a hefty rise, hitting projections of USD 6.0 billion by 2028 from USD 4.6 billion in 2023. This growth came at a compound annual growth rate (CAGR) of about 5.4%, thanks to shifting consumer preferences towards naturally sourced and visually appealing products. Market Dynamics: The Push for Natural Colors Back then, the processed food scene was...

Continue Reading